Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Yumi Watanabe Maki Gouda Nobuya Inagaki |
| Publication date | February 8, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |